{"entity":{"type":"insider","cik":"0001449211","url":"/insider/0001449211","json_url":"/insider/0001449211.json","name":"Greenspan Ira Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":11,"first":"2018-06-05","last":"2021-08-30","span_basis":"filed_date"},"name_variants":[{"name":"Greenspan Ira Scott","source":"filing","n_filings":11,"first_seen":"2018-06-05","last_seen":"2021-08-30"}],"transactions":[{"id":5097421,"accession":"0001104659-21-110764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-110764","line_url":"/filing/0001104659-21-110764","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":4.972666666666667,"price_display":"4.97","price_state":"stated","total_value":4475.4,"total_display":"4,475.40","total_whole":"4,475","shares_owned_after":14640.0,"shares_owned_after_display":"14,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-30","scope":"insider","n_lines":2},{"id":4514825,"accession":"0001104659-21-109182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-109182","line_url":"/filing/0001104659-21-109182#line-2","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50.0,"shares_display":"50","price_per_share":4.65,"price_display":"4.65","price_state":"stated","total_value":232.5,"total_display":"232.50","total_whole":"233","shares_owned_after":82340.0,"shares_owned_after_display":"82,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-24","filed_date":"2021-08-25","scope":"insider"},{"id":4514821,"accession":"0001104659-21-109182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-109182","line_url":"/filing/0001104659-21-109182#line-1","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.41,"price_display":"4.41","price_state":"stated","total_value":2205.0,"total_display":"2,205.00","total_whole":"2,205","shares_owned_after":82290.0,"shares_owned_after_display":"82,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-25","scope":"insider"},{"id":4365968,"accession":"0001104659-21-108376","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-108376","line_url":"/filing/0001104659-21-108376#line-2","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":4.23,"price_display":"4.23","price_state":"stated","total_value":1692.0,"total_display":"1,692.00","total_whole":"1,692","shares_owned_after":81790.0,"shares_owned_after_display":"81,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-20","filed_date":"2021-08-23","scope":"insider"},{"id":4365962,"accession":"0001104659-21-108376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-108376","line_url":"/filing/0001104659-21-108376#line-1","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.04,"price_display":"4.04","price_state":"stated","total_value":8080.0,"total_display":"8,080.00","total_whole":"8,080","shares_owned_after":13850.0,"shares_owned_after_display":"13,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-23","scope":"insider"},{"id":5097351,"accession":"0001104659-21-107826","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-107826","line_url":"/filing/0001104659-21-107826#line-2","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":4270.0,"total_display":"4,270.00","total_whole":"4,270","shares_owned_after":11850.0,"shares_owned_after_display":"11,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-19","scope":"insider"},{"id":5097344,"accession":"0001104659-21-107826","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-107826","line_url":"/filing/0001104659-21-107826#line-1","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":4130.0,"total_display":"4,130.00","total_whole":"4,130","shares_owned_after":10850.0,"shares_owned_after_display":"10,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":5051702,"accession":"0001104659-21-096344","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-096344","line_url":"/filing/0001104659-21-096344#line-4","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":4.54,"price_display":"4.54","price_state":"stated","total_value":908.0,"total_display":"908.00","total_whole":"908","shares_owned_after":81390.0,"shares_owned_after_display":"81,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-27","filed_date":"2021-07-27","scope":"insider"},{"id":5051695,"accession":"0001104659-21-096344","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-096344","line_url":"/filing/0001104659-21-096344","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":4.774285714285714,"price_display":"4.77","price_state":"stated","total_value":6684.0,"total_display":"6,684.00","total_whole":"6,684","shares_owned_after":9850.0,"shares_owned_after_display":"9,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-27","scope":"insider","n_lines":2},{"id":5051680,"accession":"0001104659-21-096344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-096344","line_url":"/filing/0001104659-21-096344#line-1","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":4.77,"price_display":"4.77","price_state":"stated","total_value":5247.0,"total_display":"5,247.00","total_whole":"5,247","shares_owned_after":8850.0,"shares_owned_after_display":"8,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-27","scope":"insider"},{"id":5141076,"accession":"0001104659-21-028948","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-028948","line_url":"/filing/0001104659-21-028948#line-3","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":9.01,"price_display":"9.01","price_state":"stated","total_value":7208.0,"total_display":"7,208.00","total_whole":"7,208","shares_owned_after":7750.0,"shares_owned_after_display":"7,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-25","filed_date":"2021-02-26","scope":"insider"},{"id":5141072,"accession":"0001104659-21-028948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-028948","line_url":"/filing/0001104659-21-028948","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":415.0,"shares_display":"415","price_per_share":9.458313253012049,"price_display":"9.46","price_state":"stated","total_value":3925.2,"total_display":"3,925.20","total_whole":"3,925","shares_owned_after":6950.0,"shares_owned_after_display":"6,950","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-24","filed_date":"2021-02-26","scope":"insider","n_lines":2},{"id":4210583,"accession":"0001104659-21-027147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-027147","line_url":"/filing/0001104659-21-027147","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":9.649333333333333,"price_display":"9.65","price_state":"stated","total_value":14474.0,"total_display":"14,474.00","total_whole":"14,474","shares_owned_after":6650.0,"shares_owned_after_display":"6,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-24","scope":"insider","n_lines":2},{"id":4767352,"accession":"0001104659-21-026463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-026463","line_url":"/filing/0001104659-21-026463#line-1","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":10.05,"price_display":"10.05","price_state":"stated","total_value":4522.5,"total_display":"4,522.50","total_whole":"4,523","shares_owned_after":5350.0,"shares_owned_after_display":"5,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-02-23","scope":"insider"},{"id":4100702,"accession":"0001104659-21-025419","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-025419","line_url":"/filing/0001104659-21-025419#line-4","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":10.04,"price_display":"10.04","price_state":"stated","total_value":22088.0,"total_display":"22,088.00","total_whole":"22,088","shares_owned_after":4900.0,"shares_owned_after_display":"4,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-18","scope":"insider"},{"id":4100699,"accession":"0001104659-21-025419","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-025419","line_url":"/filing/0001104659-21-025419","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":675.0,"shares_display":"675","price_per_share":9.725555555555555,"price_display":"9.73","price_state":"stated","total_value":6564.75,"total_display":"6,564.75","total_whole":"6,565","shares_owned_after":80475.0,"shares_owned_after_display":"80,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider","n_lines":2},{"id":4100692,"accession":"0001104659-21-025419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-025419","line_url":"/filing/0001104659-21-025419#line-1","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"Scopus BioPharma Inc.","issuer_ticker":"SCPS","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Director, Officer (Executive Committee Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Committee Chairman","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":10.2,"price_display":"10.20","price_state":"stated","total_value":25500.0,"total_display":"25,500.00","total_whole":"25,500","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":6788585,"accession":"0001144204-18-033789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-033789","line_url":"/filing/0001144204-18-033789#line-1","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"PAVmed Inc.","issuer_ticker":"PAVM","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18300.0,"shares_display":"18,300","price_per_share":1.04,"price_display":"1.04","price_state":"stated","total_value":19032.0,"total_display":"19,032.00","total_whole":"19,032","shares_owned_after":421691.0,"shares_owned_after_display":"421,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-11","scope":"insider"},{"id":6813078,"accession":"0001144204-18-032917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-032917","line_url":"/filing/0001144204-18-032917#line-1","is_derivative":false,"issuer_cik":"0001449211","issuer_name":"PAVmed Inc.","issuer_ticker":"PAVM","issuer_name_source":null,"issuer_url":"/issuer/0001449211","owner_cik":"0001449211","owner_name":"Greenspan Ira Scott","owner_display_name":"Greenspan Ira Scott","owner_url":"/insider/0001449211","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":532255.0,"shares_display":"532,255","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":516287.35,"total_display":"516,287.35","total_whole":"516,287","shares_owned_after":439991.0,"shares_owned_after_display":"439,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001772028","name":"Scopus BioPharma Inc.","url":"/issuer/0001772028","role":"Director, Officer (Executive Committee Chairman), Ten percent owner","n_filings":9,"first_seen":"2021-02-18","last_seen":"2021-08-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001624326","name":"PAVmed Inc.","url":"/issuer/0001624326","role":"Ten percent owner","n_filings":2,"first_seen":"2018-06-05","last_seen":"2018-06-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001449211","retrieved_at":"2026-08-22T14:55:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}